News | April 01, 2025
Lonza implements streamlined operating model
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Positions Curium as leading manufacturer of Lu-177 isotope
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Subscribe To Our Newsletter & Stay Updated
